Orthonika is a pre-clinical spin-out company from Imperial College London developing a novel total meniscus replacement for the knee joint.
Orthonika has raised $1.7M in total funding. The most recent round was Grant. The last funding was announced in May 2023.
Orthonika's investors include Innovate UK.
Orthonika is headquartered in London, United Kingdom.
Orthonika is a pre-clinical spin-out company from Imperial College London developing a novel total meniscus replacement for the knee joint.
Orthonika is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Orthonika — Funding & Investors." VCBacked, May 31, 2023, https://www.vcbacked.co/company/orthonika. Accessed August 14, 2026.
VCBacked. (2023). Orthonika — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/orthonika
{{cite web |title=Orthonika — Funding & Investors |url=https://www.vcbacked.co/company/orthonika |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated